Evidence map›Paper›PMID 31770052›Full record

ArticleJournal of global oncology2019

Breast Cancer Care Quality in South Africa's Public Health System: An Evaluation Using American Society of Clinical Oncology/National Quality Forum Measures.

Daniel S O'Neil, Wenlong Carl Chen, Oluwatosin Ayeni, Sarah Nietz, Ines Buccimazza, Urishka Singh, Sharon Čačala, Laura Stopforth, Maureen Joffe, Katherine D Crew and 4 more

Open access · goldAbstract read
In one paragraph

Article in Journal of global oncology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 2 pooled it
0.8field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 2 syntheses or guidelines pooled it, 21 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 7 institutions in 2 countries.

Daniel S O'NeilUniversity of Miami Leonard M. Miller School of Medicine, Miami, FL.
Wenlong Carl ChenWits Health Consortium, Johannesburg, South Africa.
Oluwatosin AyeniWits Health Consortium, Johannesburg, South Africa.
Sarah NietzWits Health Consortium, Johannesburg, South Africa.
Ines BuccimazzaWits Health Consortium, Johannesburg, South Africa.
Urishka SinghWits Health Consortium, Johannesburg, South Africa.
Sharon ČačalaWits Health Consortium, Johannesburg, South Africa.
Laura StopforthWits Health Consortium, Johannesburg, South Africa.
Maureen JoffeWits Health Consortium, Johannesburg, South Africa.
Katherine D CrewColumbia University, New York, NY.
Judith S JacobsonColumbia University, New York, NY.
Alfred I NeugutColumbia University, New York, NY.
Paul RuffWits Health Consortium, Johannesburg, South Africa.
Herbert CubaschWits Health Consortium, Johannesburg, South Africa.
Africa Health Research Institute · ZAColumbia University · USUniversity of the Witwatersrand · ZAUniversity of KwaZulu-Natal · ZAChris Hani Baragwanath Hospital · ZAGrey's Hospital · ZAUniversity of Miami · US

Funding

Tumor Biology and Microenvironment ProgramP30CA013696 · NCI · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI Parisa Tehranifar · 1985 to 2026
$115.3M
HIV's Effects on Breast Cancer Treatment and Outcomes in South AfricaR01CA192627 · NCI · WITS HEALTH CONSORTIUM (PTY), LTD · PI JACOBSON, JUDITH S, JOFFE, MAUREEN · 2015 to 2019
$1.7M
NCI NIH HHS P30 CA013696NCI NIH HHS R01 CA192627
6 · The paper itself

Abstract

purposeThe quality of breast cancer care in sub-Saharan Africa contributes to the region's dismal breast cancer mortality. ASCO has issued quality measures focusing on delivery of adjuvant chemotherapy, radiotherapy, and endocrine therapy. We applied these measures in five South African public hospitals and analyzed factors associated with care concordance. MATERIALS AND

methodsAmong 1,736 women with breast cancer who were enrolled in the South African Breast Cancer and HIV Outcomes study over 24 months, we evaluated care using ASCO's three measures. We also evaluated adjuvant chemotherapy receipt in 957 women with an indication. We used logistic regression to estimate associations between measure-concordant care and patient factors.

resultsOf 235 women with hormone receptor-negative cancer, 173 (74%) began adjuvant chemotherapy within 120 days from diagnosis. Of 194 patients who received breast-conserving surgery, 73 (37%) began radiotherapy within 365 days from diagnosis. Of 999 women with hormone receptor-positive cancer, 719 (72%) initiated endocrine therapy within 365 days from diagnosis. Chemotherapy and radiotherapy measure-concordant care were more common among women residing < 20 km from the hospital (odds ratio [OR], 1.79; 95% CI, 1.32 to 2.44 and OR, 3.17; 95% CI, 1.57 to 6.42). Endocrine therapy measure-concordant care was more common among English-speaking women (OR, 2.12; 95% CI, 1.12 to 4.02). Participating hospitals varied in care concordance. HIV infection did not affect care quality.

conclusionMore timely delivery of chemotherapy, radiotherapy, and endocrine therapy is needed in South Africa, particularly for women living > 20 km from the hospital or not speaking English. Focused quality improvement efforts could support that goal.

Indexed as

Quality of Health CareAdultAntineoplastic AgentsBreast NeoplasmsFemaleHumansMiddle AgedSouth AfricaAntineoplastic Agents

Identifiers

PMID31770052
PMCPMC6882520
OpenAlexW2991532691

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.